Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials

European Heart Journal

Volumn 28, Issue 4, 2007, Pages 425-432

  Mahaffey, Kenneth W ^a   Roe, Matthew T ^a   Kilaru, Rakhi ^a   Alexander, John H ^a   Van De Werf, Frans ^b   Califf, Robert M ^b   Simoons, Maarten L ^c   Topol, Eric J ^d   Harrington, Robert A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute coronary syndrome; Clinical endpoints; Coronary artery bypass graft; Creatine kinase MB elevation; Myocardial infarction

Indexed keywords

CREATINE KINASE MB;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXPERIMENTATION; FEMALE; GENDER; GROUPS BY AGE; HEART INFARCTION; HEART RATE; HOSPITAL PERSONNEL; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

AGED; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS; CORONARY DISEASE; CREATINE KINASE, MB FORM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 34548410032     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl483     Document Type: Article

References (26)

1. Gray RJ, Matloff JM, Conklin CM, Ganz W, Charuzi Y, Wolfstein R, Swan HJ. Perioperative myocardial infarction: late clinical course after coronary artery bypass surgery. Circulation 1982;66:1185-1189.
2. Roberts AJ, Spies SM, Lichtenthal PR, Moran JM, Sanders JH, Michaelis LL. Changes in left ventricular performance related to perioperative myocardial infarction in coronary artery bypass graft surgery. Ann Thorac Surg 1983;35:516-524.
3. Codd JE, Wiens RD, Kaiser GC, Barner HB, Tyras DH, Mudd JG, Willman VL. Late sequelae of perioperative myocardial infarction. Ann Thorac Surg 1978;26:208-214.
4. Force T, Hibberd P, Weeks G, Kemper AJ, Bloomfield P, Tow D, Josa M, Khuri S, Parisi AF. Perioperative myocardial infarction after coronary artery bypass surgery: clinical significance and approach to risk stratification. Circulation 1990;82:903-912.
5. Namay DL, Hammermeister KE, Zia MS, DeRouen TA, Dodge HT, Namay K. Effect of perioperative myocardial infarction on late survival in patients undergoing coronary artery bypass surgery. Circulation 1982;65:1066-1071.
6. Schaff HV, Gersh BJ, Fisher LD, Frye RL, Mock MB, Ryan TJ, Ells RB, Chaitman BR, Alderman EL, Kaiser GC. Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass: report from the Coronary Artery Surgery Study-CASS. J Thorac Cardiovasc Surg 1984;88:972-981.
7. McGregor CGA, Muir AL, Smith AF, Miller HC, Hannan WJ, Cameron EW, Wheatley DJ. Myocardial infarction related to coronary artery bypass graft surgery. Br Heart J 1984;51:399-406.
8. Marso SP, Bliven BD, House JA, Muehlebach GF, Borkon AM. Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality. Eur Heart J 2003;24:1323-1328.
9. Verrier ED, Shernan SK, Taylor KM, Van de Werf F, Newman MF, Chen JC, Carrier M, Haverich A, Malloy KJ, Adams PX, Todaro TG, Mojcik CF, Rollins SA, Levy JH, PRIMO-CABG Investigators. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 2004;291:2319-2327.
10. Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, Bartels C, Keller B, Jessel A, GUARDIAN Investigators (The GUARD during Ischemia Against Necrosis). Increased mortality after coronary artery bypass graft surgery is associated with increased levels of post-operative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol 2001;38:1070-1077.
11. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, Roose PC, van Geldorp TR, Macaya C, Castanon JL, Fernandez-Avilez F, Gonzales JH, Heyer G, Unger F, Serruys PW. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001;104:2689-2693.
12. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 2002;40:1961-1967.
13. The PURSUIT Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-443.
14. Simoons ML, GUSTO IV-ACS Investigators. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 2001;357:1915-1924.
15. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H. Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004;292:45-54.
16. Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J 2004;25:313-321.
17. The GUSTO-IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775-782.
18. The PARAGON Investigators. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation 1998;97:2386-2395.
19. The PARAGON-B Investigators. Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes. Circulation 2002;105:316-321.
20. Boersma E, Piper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, Akkerhuis KM, Harrington RA, Deckers JW, Armstrong PW, Lincoff AM, Califf RM, Topol EJ, Simoons ML. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 2000;101:2557-2567.
21. Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S, Collins P, Wang D, Sigwart U, Pepper J. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004;350:21-28.
22. Dyke CK, Roe MT, Cohen DJ, Ohman EM, Bhatt DL, Lytle BL, Saucedo JF, Smith SC Jr. Patients with non-ST-segment elevation acute coronary syndromes receive less aggressive discharge care after bypass surgery versus percutaneous coronary intervention. (Abstract 1980). Circulation 2004; 110(Suppl. III):420.
23. Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, Neubauer S. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004;110:1535-1541.
24. Selvanayagam JB, Petersen SE, Francis JM, Robson MD, Kardos A, Neubauer S, Taggart DP. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004;109:345-350.
25. Steuer J, Bjerner T, Duvernoy, Jideus L, Johansson L, Ahlstrom H, Stahle E, Lindahl B. Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J 2004;25:1293-1299.
26. Alpert JS, Thygesen K. Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-969.